346 related articles for article (PubMed ID: 8122662)
1. Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease.
Chan CY; Baker AL
Am J Gastroenterol; 1994 Mar; 89(3):442-3. PubMed ID: 8122662
[TBL] [Abstract][Full Text] [Related]
2. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of Wilson's disease: results of a single center experience.
Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
[TBL] [Abstract][Full Text] [Related]
4. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
5. Successful long term oral zinc in florid Wilson's disease: a case report.
Kaur U; Bambery P; Bhushnurmath SR; Deodhar SD; Dilawari JB
Trop Geogr Med; 1988 Apr; 40(2):161-5. PubMed ID: 3407008
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
Schumacher G; Platz KP; Mueller AR; Neuhaus R; Steinmüller T; Bechstein WO; Becker M; Luck W; Schuelke M; Neuhaus P
Clin Transplant; 1997 Jun; 11(3):217-24. PubMed ID: 9193846
[TBL] [Abstract][Full Text] [Related]
7. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
[TBL] [Abstract][Full Text] [Related]
8. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
[TBL] [Abstract][Full Text] [Related]
9. [Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease].
Storch W; Berger H
Z Gesamte Inn Med; 1980 Jul; 35(13):567-70. PubMed ID: 7445606
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
Haslam RH; Sass-Kortsak A; Stout W; Berg M
Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
[TBL] [Abstract][Full Text] [Related]
11. The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1).
Walshe JM
Prog Clin Biol Res; 1979; 34():271-80. PubMed ID: 531055
[No Abstract] [Full Text] [Related]
12. Wilson's disease presenting as haemolytic anaemia and its successful treatment with penicillamine and zinc.
Kong HL; Yap IL; Kueh YK
Singapore Med J; 1996 Dec; 37(6):670-2. PubMed ID: 9104075
[TBL] [Abstract][Full Text] [Related]
13. [Pemphigus in a patient treated with penicillamine for Wilson's disease].
Degos R; Touraine R; Belaïch S; Revuz J
Bull Soc Fr Dermatol Syphiligr; 1969; 76(6):751-3. PubMed ID: 5384189
[No Abstract] [Full Text] [Related]
14. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
Germinario L; Campanella G; D'Addabbo A
Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
[No Abstract] [Full Text] [Related]
15. Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc.
Askari FK; Greenson J; Dick RD; Johnson VD; Brewer GJ
J Lab Clin Med; 2003 Dec; 142(6):385-90. PubMed ID: 14713890
[TBL] [Abstract][Full Text] [Related]
16. [Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
Ritland S
Tidsskr Nor Laegeforen; 1987 Aug; 107(22):1770-1. PubMed ID: 3660361
[No Abstract] [Full Text] [Related]
17. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
18. [Cutis hyperelastica following prolonged administration of penicillamine in a patient with Wilson's disease].
Charlebois G; Cadotte M; Barbeau A
Union Med Can; 1972 May; 101(5):893-5. PubMed ID: 4666894
[No Abstract] [Full Text] [Related]
19. Ophthalmoscopic changes in a patient with Wilson's disease during long-term penicillamine therapy.
Dingle J; Havener WH
Ann Ophthalmol; 1978 Sep; 10(9):1227-30. PubMed ID: 736410
[TBL] [Abstract][Full Text] [Related]
20. [Nephrotic syndrome after treatment with penicillamine in Wilson's disease].
Hampel R; Meng W; Kallwellis G
Z Gesamte Inn Med; 1976 Jul; 31(13):507-11. PubMed ID: 960872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
